Human metabolic transformation of quercetin blocks its capacity to decrease endothelial nitric oxide synthase (eNOS) expression and endothelin-1 secretion by human endothelial cells.
暂无分享,去创建一个
P. Kroon | D. Hughes | Mark S. Winterbone | F. Lodi | P. Needs | S. Tribolo | S. Saha
[1] S. Ebeler,et al. UHPLC-(ESI)QTOF MS/MS profiling of quercetin metabolites in human plasma postconsumption of applesauce enriched with apple peel and onion. , 2012, Journal of agricultural and food chemistry.
[2] F. Perez-Vizcaino,et al. The flavonoid paradox: conjugation and deconjugation as key steps for the biological activity of flavonoids. , 2012, Journal of the science of food and agriculture.
[3] L. Moreno,et al. Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed? , 2011, Molecular nutrition & food research.
[4] P. Kroon,et al. Quercetin and its principal metabolites, but not myricetin, oppose lipopolysaccharide‐induced hyporesponsiveness of the porcine isolated coronary artery , 2011, British journal of pharmacology.
[5] Weina Gao,et al. Cholesterol metabolism is modulated by quercetin in rats. , 2011, Journal of agricultural and food chemistry.
[6] G. Douglas,et al. The pathogenesis of atherosclerosis , 2010 .
[7] Takafumi Inoue,et al. Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. , 2010, Free radical biology & medicine.
[8] G. Tucker,et al. Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. , 2010, The British journal of nutrition.
[9] J. Hodgson,et al. Specific Dietary Polyphenols Attenuate Atherosclerosis in Apolipoprotein E–Knockout Mice by Alleviating Inflammation and Endothelial Dysfunction , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[10] P. Kroon,et al. Quercetin and its major metabolites selectively modulate cyclic GMP‐dependent relaxations and associated tolerance in pig isolated coronary artery , 2010, British journal of pharmacology.
[11] L. Moreno,et al. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. , 2009, Atherosclerosis.
[12] J. Schrezenmeir,et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study , 2009, British Journal of Nutrition.
[13] Bochu Wang,et al. DNA binding and oxidative DNA damage induced by a quercetin copper(II) complex: potential mechanism of its antitumor properties , 2009, JBIC Journal of Biological Inorganic Chemistry.
[14] P. Kroon,et al. Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. , 2009, Atherosclerosis.
[15] J. Hodgson,et al. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. , 2008, The American journal of clinical nutrition.
[16] J. Salonen,et al. Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study , 2008, International journal of cancer.
[17] Ian Harvey,et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. , 2008, The American journal of clinical nutrition.
[18] F. Perez-Vizcaino,et al. Glucuronidated metabolites of the flavonoid quercetin do not auto-oxidise, do not generate free radicals and do not decrease nitric oxide bioavailability. , 2008, Planta medica.
[19] J. Hodgson,et al. Quercetin and its in vivo metabolites inhibit neutrophil-mediated low-density lipoprotein oxidation. , 2008, Journal of agricultural and food chemistry.
[20] N. Shibata,et al. Macrophage as a Target of Quercetin Glucuronides in Human Atherosclerotic Arteries , 2008, Journal of Biological Chemistry.
[21] Moira A. Taylor,et al. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. , 2008, Atherosclerosis.
[22] J. Hodgson,et al. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. , 2008, Biochemical pharmacology.
[23] S. Litwin,et al. Quercetin reduces blood pressure in hypertensive subjects. , 2007, The Journal of nutrition.
[24] F. Mattivi,et al. A novel model to study the biological effects of red wine at the molecular level , 2007, British Journal of Nutrition.
[25] P. Kroon,et al. Convenient syntheses of metabolically important quercetin glucuronides and sulfates , 2006 .
[26] R. Venema,et al. Quercetin inhibits eNOS, microtubule polymerization, and mitotic progression in bovine aortic endothelial cells. , 2006, The Journal of nutrition.
[27] D. Barron,et al. Divergent effects of quercetin conjugates on angiogenesis , 2006, British Journal of Nutrition.
[28] S. Litwin,et al. Quercetin-Supplemented Diets Lower Blood Pressure and Attenuate Cardiac Hypertrophy in Rats With Aortic Constriction , 2006, Journal of cardiovascular pharmacology.
[29] J. Tamargo,et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats , 2006, Journal of hypertension.
[30] C. Edwards,et al. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions , 2006, British Journal of Nutrition.
[31] J. Fish,et al. Epigenetic Basis for the Transcriptional Hyporesponsiveness of the Human Inducible Nitric Oxide Synthase Gene in Vascular Endothelial Cells1 , 2005, The Journal of Immunology.
[32] K. Naseem. The role of nitric oxide in cardiovascular diseases. , 2005, Molecular aspects of medicine.
[33] V. Schini-Kerth,et al. Vascular protection by dietary polyphenols. , 2004, European journal of pharmacology.
[34] G. Williamson,et al. How should we assess the effects of exposure to dietary polyphenols in vitro? , 2004, The American journal of clinical nutrition.
[35] J. Duarte,et al. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats , 2004, Molecular and Cellular Biochemistry.
[36] J. Tamargo,et al. Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. , 2004, Molecular pharmacology.
[37] E. Choi,et al. Anti- and prooxidant effects of chronic quercetin administration in rats. , 2003, European journal of pharmacology.
[38] G. Yen,et al. Pro-oxidative Properties of Flavonoids in Human Lymphocytes , 2003, Bioscience, biotechnology, and biochemistry.
[39] W. Klaus,et al. Nitric Oxide Formation and Corresponding Relaxation of Porcine Coronary Arteries Induced by Plant Phenols: Essential Structural Features , 2002, Journal of cardiovascular pharmacology.
[40] J. Tamargo,et al. Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. , 2002, The Journal of pharmacology and experimental therapeutics.
[41] Martin J. Carrier,et al. Health: Endothelin-1 synthesis reduced by red wine , 2001, Nature.
[42] K. Shimoi,et al. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[43] W. Sly,et al. Flavonoid glucuronides are substrates for human liver β‐glucuronidase , 2001 .
[44] K. O'Leary,et al. Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4'-glucoside. , 2001, The Journal of nutrition.
[45] J. Tamargo,et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats , 2001, British journal of pharmacology.
[46] F. Hu,et al. Dietary modulation of endothelial function: implications for cardiovascular disease. , 2001, The American journal of clinical nutrition.
[47] D. Barron,et al. Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin , 2001, Free radical research.
[48] C. Yuan,et al. Effects of quercetin on the release of endothelin, prostacyclin and tissue plasminogen activator from human endothelial cells in culture. , 1999, Journal of ethnopharmacology.
[49] K. Hirata,et al. Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression. , 1998, Hypertension.
[50] R. Ross,et al. Atherosclerosis is an Inflammatory Disease , 1998 .
[51] M. Chiesi,et al. Inhibition of constitutive endothelial NO-synthase activity by tannin and quercetin. , 1995, Biochemical pharmacology.
[52] S. Moncada,et al. The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.
[53] H. Rus,et al. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. , 1991, Atherosclerosis.
[54] I. Arts,et al. Some phenolic compounds increase the nitric oxide level in endothelial cells in vitro. , 2009, Journal of agricultural and food chemistry.
[55] J. Segura-Aguilar,et al. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. , 1999, Free radical biology & medicine.
[56] R. Prior,et al. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. , 1997, Free radical biology & medicine.
[57] D Kromhout,et al. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. , 1993, Nutrition and cancer.